Boston Scientific (BSX) Depreciation and Depletion (2020 - 2026)

Boston Scientific (BSX) has 7 years of Depreciation and Depletion data on file, last reported at $89.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion fell 16.04% year-over-year to $89.0 million; the trailing twelve-month figure through Mar 2026 stood at $454.0 million (up 6.07% YoY), and the FY2025 full-year result was $471.0 million, up 14.32% from the prior year.
• Depreciation and Depletion retreated to $89.0 million in Q1 2026, from $137.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $137.0 million in Q4 2025 to a low of $76.0 million in Q1 2022.
• A 5-year average of $98.4 million and a median of $95.0 million in 2022 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion grew 17.78% in 2025 and fell 16.04% in 2026, its largest moves.
• Tracing BSX's Depreciation and Depletion over 5 years: stood at $95.0 million in 2022, then gained by 9.47% to $104.0 million in 2023, then climbed by 17.31% to $122.0 million in 2024, then rose by 12.3% to $137.0 million in 2025, then slumped by 35.04% to $89.0 million in 2026.
• Business Quant data shows BSX's Depreciation and Depletion at $89.0 million in Q1 2026, $137.0 million in Q4 2025, and $117.0 million in Q3 2025.